depemokimabasthmatype 2
…in the SWIFT-1/2 studies, 260 received placebo and 502 received depemokimab. Depemokimab was associated with reduced exacerbation rates ver…
Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
…in the SWIFT-1/2 studies, 260 received placebo and 502 received depemokimab. Depemokimab was associated with reduced exacerbation rates ver…
… in patients on medium- vs high-dose ICS (figure 1).Conclusions Depemokimab reduces exacerbations in patfients with asthma across baseline …
… an appetite for engagement with an upcoming 6-monthly biologic Depemokimab.…